Hospice symptom management

Hospice delirium management

Delirium is a hallmark of the last days of life and affects up to 80% of hospice patients before death. Recognition, gentle communication with family, and targeted symptom relief are more important than aggressive investigation late in the disease course.

By Goodwin Hospice Academy Editorial Team·Published February 16, 2026

Educational content only. Individual clinicians must confirm current dosing and drug availability against their hospice medical director and current formulary. This is not a substitute for your hospice’s policies or your medical director’s clinical judgment.

Quick framework

Delirium subtypes: hyperactive (agitated, restless), hypoactive (withdrawn, lethargic), mixed.
Assess with the Confusion Assessment Method (CAM) or a validated hospice-adapted tool.
Address reversible triggers only if aligned with goals of care: uncontrolled pain, urinary retention, constipation, hypercalcemia, medication side effects.
First-line pharm: haloperidol 0.5–2 mg PO/SC q6h scheduled with q1h prn.
Avoid benzodiazepines as monotherapy — they can worsen delirium (paradoxical excitation). Reserve for delirium tremens or when antipsychotics fail.

Pharmacology

01Haloperidol 0.5–2 mg PO or SC every 6 hours scheduled + q1h prn is the palliative-care first-line for hyperactive delirium.
02Chlorpromazine 25–50 mg PO or 12.5–25 mg IV/SC/PR for delirium with agitation and pain (more sedating than haloperidol).
03Olanzapine 2.5–5 mg PO or ODT QHS for delirium at night with concomitant nausea.
04Risperidone 0.25–0.5 mg PO BID is an alternative when parkinsonism is a concern (though even second-generations carry EPS risk).
05Lorazepam 0.5–1 mg PO/SL/SC q4–6h ONLY as add-on when antipsychotic alone is insufficient, or as first-line in alcohol/benzodiazepine withdrawal delirium.

Non-pharmacological approaches

Reorient gently: name, place, time, why they’re here. Repeat kindly.
Ensure glasses and hearing aids are in place.
Reduce environmental stimulation; keep lighting appropriate to time of day (dim at night, bright by day).
Family presence; encourage familiar objects, photos, music.
Toileting schedule to reduce urinary retention or missed calls.
Avoid physical restraints — they escalate agitation and cause injury.

When to escalate

Agitation risking patient safety (bed exit attempts, harm to self or others) not controlled with first-line pharm.
Concern for opioid-induced neurotoxicity (myoclonus + hallucinations + hyperalgesia); consider opioid rotation.
Terminal restlessness late in the dying process — consider continuous SC infusion or GIP-level care for symptom crisis.

Documentation example

A composite narrative illustrating a defensible chart entry (identifying details fictionalized):

Patient (day 3 of expected active dying) becomes restless, picking at sheets, calling out. On morphine 20 mg PO q4h. No urinary retention, no constipation, no fever. Started haloperidol 0.5 mg SC q6h + 0.5 mg q1h prn. Family reassured that this is common in the last days; educated on gentle reorientation and non-pharmacological approaches. Plan to reassess in 2 hours.

FAQ

What is terminal restlessness?

Terminal restlessness (also called terminal agitation) is delirium in the final hours to days of life, often with a hyperactive component. It is a symptom-management crisis, not a moral or spiritual failing of the patient. Treat with haloperidol first-line; escalate to continuous SC infusion if needed.

Should we always check for reversible causes?

Match the workup to goals of care. In the last days of life, checking a UA or basic metabolic panel is not helpful. Earlier in the hospice course, checking for constipation, urinary retention, medication interactions, and hypercalcemia is often high-yield.

Why not just use lorazepam?

Lorazepam alone can worsen delirium in elderly patients (paradoxical excitation). Use haloperidol as the primary agent, and add lorazepam only if antipsychotic alone is insufficient.

Grow every hospice competency, one symptom at a time.

Save this article to your team’s reading list and unlock deeper Goodwin Hospice Academy modules on hospice symptom management.

Create your free account Back to all symptoms

Hospice symptom management hub

What is GIP?

Sources

Educational content only. Not a substitute for your organization’s policies, your medical director’s clinical judgment, or current hospice formulary.